Dupixent Market to Reach USD 28.70 Billion by 2034 Driven by Expanding Biologic Therapy Demand in Chronic Inflammatory Diseases
The global Dupixent Market is on a robust growth trajectory, projected to rise from USD 13.96 billion in 2024 to USD 28.70 billion by 2034, expanding at a compound annual growth rate (CAGR) of 7.5% over the forecast period (2025–2034). This momentum is fueled by the increasing prevalence of type 2 inflammatory diseases—notably atopic...
0 Comments 0 Shares 50 Views 0 Reviews